Induced Pluripotent Stem Cells (iPSCs)
Cyagen’s iPSC services provide high-efficiency reprogramming, precise gene editing, and optimized differentiation for disease modeling, drug discovery, and regenerative medicine.
Optimized Differentiation
≥95% marker expression for high-purity cells.
Advanced Gene Editing
Optimized HDR up to 50%, KO efficiency 90%.
Efficient Reprogramming
Non-integrating method with 99% success rate.
Overview
Workflow
FAQs
Comprehensive iPSC Solutions
Cyagen provides comprehensive iPSC solutions designed to support various research applications, including iPSC reprogramming, gene editing, and directed differentiation.
— For iPSC reprogramming, we generate high-quality iPSC lines from somatic cells using non-integrating methods, ensuring genetic stability. Each iPSC line undergoes pluripotency and karyotype validation to meet rigorous research standards.
— Our iPSC gene editing services enable precise genetic modifications, including knockout, knock-in, and point mutations. With our optimized HDR technology, we achieve up to 50% efficiency, enhancing the accuracy and success rate of genome edits.
— For iPSC differentiation, we provide specialized cell models, including neurons, blood cells, and liver organoids, tailored for disease research and drug development. Each model is validated through immunofluorescence and qPCR to ensure functionality and reproducibility.
— For iPSC reprogramming, we generate high-quality iPSC lines from somatic cells using non-integrating methods, ensuring genetic stability. Each iPSC line undergoes pluripotency and karyotype validation to meet rigorous research standards.
— Our iPSC gene editing services enable precise genetic modifications, including knockout, knock-in, and point mutations. With our optimized HDR technology, we achieve up to 50% efficiency, enhancing the accuracy and success rate of genome edits.
— For iPSC differentiation, we provide specialized cell models, including neurons, blood cells, and liver organoids, tailored for disease research and drug development. Each model is validated through immunofluorescence and qPCR to ensure functionality and reproducibility.
Explore Ready-to-Use Mouse Models
Discover over 18,000 validated mouse strains—including knockout, conditional knockout, and humanized models—covering 20+ research areas such as oncology, neurology, and metabolism. All models are supported by detailed genotype data and guaranteed quality, helping you fast-track discovery with confidence.
You Might Also Be Interested In
Knockout Cell Lines Library
Browse validated human KO cell lines by gene or cell type
Tumor Cell Lines Library
Access characterized human tumor lines by cancer type or genetic status.
Cell Immunotherapy CRO Platform
CAR-T/NK development with custom vectors, models, and in vivo validation
Targeted Gene Editing
AI-enhanced HDR technology for precise in vivo genome engineering
MouseAtlas Model Library
Search and access curated genetically engineered mouse strains
AAV Vectors Library
Search and order AAVs by serotype, gene, or function
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, February, 2025
Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage
【Other】
Molecular Therapy, February, 2025
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
【Other】
Request a Custom Cell Line Consultation
Tell us about your cell line project needs. Our specialists are ready to support your research with tailored solutions.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.